Literature DB >> 18923511

The molecular neurobiology of depression.

Vaishnav Krishnan1, Eric J Nestler.   

Abstract

Unravelling the pathophysiology of depression is a unique challenge. Not only are depressive syndromes heterogeneous and their aetiologies diverse, but symptoms such as guilt and suicidality are impossible to reproduce in animal models. Nevertheless, other symptoms have been accurately modelled, and these, together with clinical data, are providing insight into the neurobiology of depression. Recent studies combining behavioural, molecular and electrophysiological techniques reveal that certain aspects of depression result from maladaptive stress-induced neuroplastic changes in specific neural circuits. They also show that understanding the mechanisms of resilience to stress offers a crucial new dimension for the development of fundamentally novel antidepressant treatments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18923511      PMCID: PMC2721780          DOI: 10.1038/nature07455

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  99 in total

1.  Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action.

Authors:  Nadia M Tsankova; Olivier Berton; William Renthal; Arvind Kumar; Rachel L Neve; Eric J Nestler
Journal:  Nat Neurosci       Date:  2006-02-26       Impact factor: 24.884

2.  Leptin: a potential novel antidepressant.

Authors:  Xin-Yun Lu; Chung Sub Kim; Alan Frazer; Wei Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-19       Impact factor: 11.205

Review 3.  New approaches to antidepressant drug discovery: beyond monoamines.

Authors:  Olivier Berton; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2006-02       Impact factor: 34.870

4.  Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children.

Authors:  Joan Kaufman; Bao-Zhu Yang; Heather Douglas-Palumberi; Damion Grasso; Deborah Lipschitz; Shadi Houshyar; John H Krystal; Joel Gelernter
Journal:  Biol Psychiatry       Date:  2006-02-03       Impact factor: 13.382

5.  TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting.

Authors:  Birgitte B Simen; Catharine H Duman; Arthur A Simen; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2006-02-03       Impact factor: 13.382

6.  Alterations in 5-HT1B receptor function by p11 in depression-like states.

Authors:  Per Svenningsson; Karima Chergui; Ilan Rachleff; Marc Flajolet; Xiaoqun Zhang; Malika El Yacoubi; Jean-Marie Vaugeois; George G Nomikos; Paul Greengard
Journal:  Science       Date:  2006-01-06       Impact factor: 47.728

7.  Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.

Authors:  Manfred Uhr; Alina Tontsch; Christian Namendorf; Stephan Ripke; Susanne Lucae; Marcus Ising; Tatjana Dose; Martin Ebinger; Marcus Rosenhagen; Martin Kohli; Stefan Kloiber; Daria Salyakina; Thomas Bettecken; Michael Specht; Benno Pütz; Elisabeth B Binder; Bertram Müller-Myhsok; Florian Holsboer
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

8.  Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia.

Authors:  Tammy J Sajdyk; Philip L Johnson; Randy J Leitermann; Stephanie D Fitz; Amy Dietrich; Michelle Morin; Donald R Gehlert; Janice H Urban; Anantha Shekhar
Journal:  J Neurosci       Date:  2008-01-23       Impact factor: 6.167

9.  Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress.

Authors:  Olivier Berton; Colleen A McClung; Ralph J Dileone; Vaishnav Krishnan; William Renthal; Scott J Russo; Danielle Graham; Nadia M Tsankova; Carlos A Bolanos; Maribel Rios; Lisa M Monteggia; David W Self; Eric J Nestler
Journal:  Science       Date:  2006-02-10       Impact factor: 47.728

10.  Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis.

Authors:  M J Knol; J W R Twisk; A T F Beekman; R J Heine; F J Snoek; F Pouwer
Journal:  Diabetologia       Date:  2006-03-07       Impact factor: 10.122

View more
  855 in total

1.  Morphological changes in subregions of hippocampus and amygdala in major depressive disorder patients.

Authors:  Zhijun Yao; Yu Fu; Jianfeng Wu; Wenwen Zhang; Yue Yu; Zicheng Zhang; Xia Wu; Yalin Wang; Bin Hu
Journal:  Brain Imaging Behav       Date:  2020-06       Impact factor: 3.978

2.  Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats.

Authors:  Tatiana Barichello; Graziele Milioli; Jaqueline S Generoso; Andreza L Cipriano; Caroline S Costa; Ana Paula Moreira; Márcia Carvalho Vilela; Clarissa M Comim; Antonio Lucio Teixeira; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2011-12-13       Impact factor: 3.575

3.  Hangover Symptoms, Heavy Episodic Drinking, and Depression in Young Adults: A Cross-Lagged Analysis.

Authors:  Thomas M Piasecki; Constantine J Trela; Robin J Mermelstein
Journal:  J Stud Alcohol Drugs       Date:  2017-07       Impact factor: 2.582

4.  Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior.

Authors:  Sade Spencer; Edgardo Falcon; Jaswinder Kumar; Vaishnav Krishnan; Shibani Mukherjee; Shari G Birnbaum; Colleen A McClung
Journal:  Eur J Neurosci       Date:  2012-10-08       Impact factor: 3.386

5.  Neuronal plasticity and antidepressant actions.

Authors:  Eero Castrén; René Hen
Journal:  Trends Neurosci       Date:  2013-02-01       Impact factor: 13.837

6.  BDNF Val66Met polymorphism tunes frontolimbic circuitry during affective contextual learning.

Authors:  Mbemba Jabbi; Brett Cropp; Tiffany Nash; Philip Kohn; J Shane Kippenhan; Joseph C Masdeu; Raghav Mattay; Bhaskar Kolachana; Karen F Berman
Journal:  Neuroimage       Date:  2017-09-01       Impact factor: 6.556

7.  L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors.

Authors:  Carla Nasca; Dionysios Xenos; Ylenia Barone; Alessandra Caruso; Sergio Scaccianoce; Francesco Matrisciano; Giuseppe Battaglia; Aleksander A Mathé; Anna Pittaluga; Luana Lionetto; Maurizio Simmaco; Ferdinando Nicoletti
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

8.  Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling.

Authors:  T Couroussé; A Bacq; C Belzung; B Guiard; L Balasse; F Louis; A-M Le Guisquet; A M Gardier; A H Schinkel; B Giros; S Gautron
Journal:  Mol Psychiatry       Date:  2014-08-05       Impact factor: 15.992

9.  Hippocampal PPARα is a novel therapeutic target for depression and mediates the antidepressant actions of fluoxetine in mice.

Authors:  Lu Song; Hao Wang; Ying-Jie Wang; Jin-Liang Wang; Qing Zhu; Feng Wu; Wei Zhang; Bo Jiang
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

10.  Novel antidepressant effects of Paeonol alleviate neuronal injury with concomitant alterations in BDNF, Rac1 and RhoA levels in chronic unpredictable mild stress rats.

Authors:  Xiu-Ling Zhu; Jing-Jing Chen; Fei Han; Chuan Pan; Ting-Ting Zhuang; Ya-Fei Cai; Ya-Ping Lu
Journal:  Psychopharmacology (Berl)       Date:  2018-05-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.